- Home
- STRO vs LAZR Comparison
STRO vs LAZR Comparison
Compare STRO & LAZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- LAZR
- Stock Information
- Founded
- STRO 2003
- LAZR 2012
- Country
- STRO United States
- LAZR United States
- Employees
- STRO N/A
- LAZR N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- LAZR Auto Parts:O.E.M.
- Sector
- STRO Health Care
- LAZR Consumer Discretionary
- Exchange
- STRO Nasdaq
- LAZR Nasdaq
- Market Cap
- STRO 172.8M
- LAZR 213.8M
- IPO Year
- STRO 2018
- LAZR N/A
- Fundamental
- Price
- STRO $1.90
- LAZR $5.16
- Analyst Decision
- STRO Strong Buy
- LAZR Hold
- Analyst Count
- STRO 7
- LAZR 9
- Target Price
- STRO $12.14
- LAZR $44.50
- AVG Volume (30 Days)
- STRO 1.4M
- LAZR 2.3M
- Earning Date
- STRO 11-13-2024
- LAZR 11-11-2024
- Dividend Yield
- STRO N/A
- LAZR N/A
- EPS Growth
- STRO N/A
- LAZR N/A
- EPS
- STRO N/A
- LAZR N/A
- Revenue
- STRO $160,955,000.00
- LAZR $75,025,000.00
- Revenue This Year
- STRO N/A
- LAZR $2.70
- Revenue Next Year
- STRO N/A
- LAZR $64.52
- P/E Ratio
- STRO N/A
- LAZR N/A
- Revenue Growth
- STRO 230.90
- LAZR 27.61
- 52 Week Low
- STRO $1.70
- LAZR $4.94
- 52 Week High
- STRO $6.13
- LAZR $55.35
- Technical
- Relative Strength Index (RSI)
- STRO 28.52
- LAZR 24.76
- Support Level
- STRO $1.70
- LAZR $4.93
- Resistance Level
- STRO $1.93
- LAZR $6.32
- Average True Range (ATR)
- STRO 0.20
- LAZR 0.56
- MACD
- STRO -0.01
- LAZR -0.02
- Stochastic Oscillator
- STRO 12.60
- LAZR 4.74
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About LAZR Luminar Technologies Inc.
Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and advanced Technologies and Services. The majority of revenue is earned from the Autonomy Solutions segment which engaged in the design, manufacturing, and sale of LiDAR sensors catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries and advanced Technologies and Services provides semiconductors and related components, as well as design, test and consulting services to the Autonomy Solutions segment and various third-party customers, including government agencies and defense contractors, in markets generally unrelated to autonomous vehicles.